Azitra (AZTR) vs Immuron (IMRN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Immuron is the larger company by market cap ($9.1 million vs $7.9 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | AZTR | IMRN |
|---|---|---|
| Share price | $0.1301 | $1.13 |
| Market cap | $7.88M | $9.12M |
| 1-day change | -1.44% | +3.67% |
| EPS (TTM) | $-0.28 | $-0.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.09 | $2.39 |
| 52-week low | $0.10 | $0.677 |
| Distance from 52-week high | -88.06% | -52.72% |
| Average volume | 1.70M | 2.06M |
| Shares outstanding | 60.60M | 8.07M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
AZTR vs IMRN FAQ
Which is bigger, Azitra or Immuron?
Immuron (IMRN) is larger, with a market capitalization of $9.12M compared with $7.88M for Azitra (AZTR).
Are Azitra and Immuron in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.